Posted on 02/24/2023 3:04:01 PM PST by ConservativeMind
Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials to support its use. Researchers completed what is believed to be the first phase I trial of intravenous Helixor M in the U.S. aimed at determining dosing for subsequent clinical trials and to evaluate safety.
Channing Paller, M.D. also documented improved quality of life and some disease control.
Mistletoe extract (ME), known as Helixor M, was studied in 21 patients with advanced and treatment-resistant cancers of various types. The phase I trial used dose escalation to determine the maximum dose that could be safely tolerated by patients. ME was delivered intravenously three times per week until disease progression or until toxicity. The study concluded that dose to be 600 milligrams of ME.
The median follow-up duration on mistletoe was 15.3 weeks. Stable disease was observed in five patients and lasted, on average, for 15 weeks. Tumors in three participants decreased in size, and remained stable for two to five months, however, this did not meet official criteria for partial response. Patients also reported overall improved quality of life via a questionnaire. The most common side effects reported were fatigue, nausea, and chills and they were noted as manageable.
Mistletoe extract is a plant with several active ingredients that, in preclinical studies, appear to directly cause the death of tumor cells and stimulate an immune response. It has been used in Europe for several decades as a complementary medicine approach to cancer treatment alone or in combination with chemotherapy and radiation therapy, but it has not been evaluated in clinical trials.
ME is not currently FDA approved for cancer treatment in the U.S. but is listed in the Homeopathic Pharmacopoeia and is offered in integrative care clinics.
(Excerpt) Read more at medicalxpress.com ...
It’s not that the mistletoe has any direct effect.
It’s all the kissing that occurs when you become walking mistletoe, that raises the spirit and crushes the cancer.💋
So far, test-tube studies suggest that frankincense may fight breast, prostate, pancreatic, skin, and colon cancer cells (25Trusted Source, 24Trusted Source, 26Trusted Source, 27, 28Trusted Source, 29Trusted Source). Test-tube studies suggest that the boswellic acids it contains might prevent cancer cells from spreading (24Trusted Source, 25Trusted Source). A research review notes that boswellic acids may also prevent the formation of DNA in cancerous cells, which could help limit cancer growth (1Trusted Source).
would there be a benefit to taking this in low dose form?
Ping
Likely the reason it’s intravenous is to bypass the liver.
Everything in our bloodstream goes through the liver.
I think it is in an IV to bypass gut absorption issues.
I wouldn’t do so, off of this study.
I would only look at it if I had cancer. I really don’t know what else it might conflict with.
Liver gets the first opportunity to filter oral drugs before the rest of body. Agents like vitamin C are given to cancer patients intravenously because the liver is so effective.
Your understanding of the process of food getting into the body is a bit off.
Our intestines directly pass nutrients into our circulatory system (blood). There is nothing that routes to the liver over all the other organs, first.
https://www.niddk.nih.gov/health-information/digestive-diseases/digestive-system-how-it-works
From Pub Med.
The article doesn’t specify the percentage of food/drugs grabbed by liver first but it’s substantial.
Mistletoe, vitamin C, quercetin are dripped intravenously over hours to bypass intestine and liver.
All blood goes through the liver, if it goes through the heart.
Think it through.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.